loadpatents
name:-0.024673938751221
name:-0.056818008422852
name:-0.0027389526367188
Hirani; Shirish Patent Filings

Hirani; Shirish

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hirani; Shirish.The latest application filed is for "prevention and reduction of blood loss".

Company Profile
2.14.21
  • Hirani; Shirish - Arlington MA
  • Hirani; Shirish - Boston MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Prevention and reduction of blood loss
Grant 11,344,610 - Ladner , et al. May 31, 2
2022-05-31
Prevention And Reduction Of Blood Loss
App 20190247477 - Ladner; Robert Charles ;   et al.
2019-08-15
Prevention and reduction of blood loss
Grant 10,245,307 - Ladner , et al.
2019-04-02
Prevention And Reduction Of Blood Loss
App 20160361395 - Ladner; Robert Charles ;   et al.
2016-12-15
Prevention and reduction of blood loss
Grant 9,480,733 - Ladner , et al. November 1, 2
2016-11-01
Kallikrein-inhibitor therapies
Grant 9,114,144 - Ladner , et al. August 25, 2
2015-08-25
Prevention And Reduction Of Blood Loss
App 20140349940 - Ladner; Robert C. ;   et al.
2014-11-27
Prevention and reduction of blood loss
Grant 8,710,007 - Ladner , et al. April 29, 2
2014-04-29
Prevention and reduction of blood loss
Grant 8,124,586 - Ladner , et al. February 28, 2
2012-02-28
Kallikrein-inhibitor Therapies
App 20120015881 - Ladner; Robert C. ;   et al.
2012-01-19
Kallikrein-inhibitor therapies
Grant 8,034,775 - Ladner , et al. October 11, 2
2011-10-11
Prevention And Reduction Of Blood Loss
App 20110086801 - Ladner; Robert C. ;   et al.
2011-04-14
Kallikrein-inhibitor therapies
Grant 7,704,949 - Ladner , et al. April 27, 2
2010-04-27
Kallikrein-inhibitor Therapies
App 20100034805 - Ladner; Robert C. ;   et al.
2010-02-11
Kallikrein-inhibitor Therapies
App 20090117130 - Ladner; Robert C. ;   et al.
2009-05-07
Prevention and Reduction of Blood Loss
App 20090082267 - Ladner; Robert C. ;   et al.
2009-03-26
Kallikrein-Inhibitor Therapies
App 20090062195 - Ladner; Robert C. ;   et al.
2009-03-05
Prevention And Reduction Of Blood Loss
App 20080260752 - Ladner; Robert C. ;   et al.
2008-10-23
Kallikrein-Inhibitor Therapies
App 20080226655 - Ladner; Robert C. ;   et al.
2008-09-18
Prevention And Reduction Of Blood Loss
App 20080152656 - Ladner; Robert C. ;   et al.
2008-06-26
Kallikrein-Inhibitor Therapies
App 20080139473 - Ladner; Robert C. ;   et al.
2008-06-12
Prevention and Reduction of Blood Loss
App 20080131426 - Ladner; Robert C. ;   et al.
2008-06-05
Prevention And Reduction Of Blood Loss
App 20080076712 - Ladner; Robert C. ;   et al.
2008-03-27
Prevention and reduction of blood loss
App 20080064637 - Ladner; Robert C. ;   et al.
2008-03-13
Prevention And Reduction Of Blood Loss
App 20070249807 - Ladner; Robert C. ;   et al.
2007-10-25
Prevention and reduction of blood loss
Grant 7,276,480 - Ladner , et al. October 2, 2
2007-10-02
Kallikrein-inhibitor Therapies
App 20070049522 - Ladner; Robert C. ;   et al.
2007-03-01
Kallikrein-inhibitor therapies
Grant 7,153,829 - Ladner , et al. December 26, 2
2006-12-26
Prevention and reduction of blood loss
App 20060194727 - Ladner; Robert C. ;   et al.
2006-08-31
Prevention and reduction of blood loss
Grant 7,064,107 - Ladner , et al. June 20, 2
2006-06-20
Kallikrein-inhibitor therapies
App 20050164928 - Ladner, Robert C. ;   et al.
2005-07-28
Prevention and reduction of blood loss
App 20040038893 - Ladner, Robert C. ;   et al.
2004-02-26
Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof
Grant 5,241,072 - Colon , et al. August 31, 1
1993-08-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed